These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 22711699)

  • 1. Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin.
    Winbanks CE; Weeks KL; Thomson RE; Sepulveda PV; Beyer C; Qian H; Chen JL; Allen JM; Lancaster GI; Febbraio MA; Harrison CA; McMullen JR; Chamberlain JS; Gregorevic P
    J Cell Biol; 2012 Jun; 197(7):997-1008. PubMed ID: 22711699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy.
    Kalista S; Schakman O; Gilson H; Lause P; Demeulder B; Bertrand L; Pende M; Thissen JP
    Endocrinology; 2012 Jan; 153(1):241-53. PubMed ID: 22087027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
    Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
    Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.
    Lokireddy S; McFarlane C; Ge X; Zhang H; Sze SK; Sharma M; Kambadur R
    Mol Endocrinol; 2011 Nov; 25(11):1936-49. PubMed ID: 21964591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of IGF-I in follistatin-induced skeletal muscle hypertrophy.
    Barbé C; Kalista S; Loumaye A; Ritvos O; Lause P; Ferracin B; Thissen JP
    Am J Physiol Endocrinol Metab; 2015 Sep; 309(6):E557-67. PubMed ID: 26219865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myostatin signaling regulates Akt activity via the regulation of miR-486 expression.
    Hitachi K; Nakatani M; Tsuchida K
    Int J Biochem Cell Biol; 2014 Feb; 47():93-103. PubMed ID: 24342526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy.
    Sepulveda PV; Lamon S; Hagg A; Thomson RE; Winbanks CE; Qian H; Bruce CR; Russell AP; Gregorevic P
    Sci Rep; 2015 Dec; 5():17535. PubMed ID: 26657343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad2 and 3 transcription factors control muscle mass in adulthood.
    Sartori R; Milan G; Patron M; Mammucari C; Blaauw B; Abraham R; Sandri M
    Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1248-57. PubMed ID: 19357234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheb, an activator of target of rapamycin, in the blackback land crab, Gecarcinus lateralis: cloning and effects of molting and unweighting on expression in skeletal muscle.
    MacLea KS; Abuhagr AM; Pitts NL; Covi JA; Bader BD; Chang ES; Mykles DL
    J Exp Biol; 2012 Feb; 215(Pt 4):590-604. PubMed ID: 22279066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of muscle mass by follistatin and activins.
    Lee SJ; Lee YS; Zimmers TA; Soleimani A; Matzuk MM; Tsuchida K; Cohn RD; Barton ER
    Mol Endocrinol; 2010 Oct; 24(10):1998-2008. PubMed ID: 20810712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myostatin and follistatin expression in skeletal muscles of rats with chronic heart failure.
    Lima AR; Martinez PF; Okoshi K; Guizoni DM; Zornoff LA; Campos DH; Oliveira SA; Bonomo C; Pai-Silva MD; Okoshi MP
    Int J Exp Pathol; 2010 Feb; 91(1):54-62. PubMed ID: 20002838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia associated with portosystemic shunting is reversed by follistatin.
    Dasarathy S; McCullough AJ; Muc S; Schneyer A; Bennett CD; Dodig M; Kalhan SC
    J Hepatol; 2011 May; 54(5):915-21. PubMed ID: 21145817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follistatin could promote the proliferation of duck primary myoblasts by activating PI3K/Akt/mTOR signalling.
    Li X; Liu H; Wang H; Sun L; Ding F; Sun W; Han C; Wang J
    Biosci Rep; 2014 Oct; 34(5):. PubMed ID: 25200144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
    Glass DJ
    Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryonic overexpression of Galgt2 inhibits skeletal muscle growth via activation of myostatin signaling.
    Chandraskeharan K; Martin PT
    Muscle Nerve; 2009 Jan; 39(1):25-41. PubMed ID: 19086062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of follistatin in trout stimulates increased muscling.
    Medeiros EF; Phelps MP; Fuentes FD; Bradley TM
    Am J Physiol Regul Integr Comp Physiol; 2009 Jul; 297(1):R235-42. PubMed ID: 19474387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of myostatin and follistatin in Mdx mice, an animal model for muscular dystrophy.
    Abe S; Soejima M; Iwanuma O; Saka H; Matsunaga S; Sakiyama K; Ide Y
    Zoolog Sci; 2009 May; 26(5):315-20. PubMed ID: 19715499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follistatin-derived peptide expression in muscle decreases adipose tissue mass and prevents hepatic steatosis.
    Nakatani M; Kokubo M; Ohsawa Y; Sunada Y; Tsuchida K
    Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E543-53. PubMed ID: 21205933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition of myostatin/TGF-β receptor/pSmad3 signaling rescues muscle regenerative responses in mouse model of type 1 diabetes.
    Jeong J; Conboy MJ; Conboy IM
    Acta Pharmacol Sin; 2013 Aug; 34(8):1052-60. PubMed ID: 23770987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of Smad3 signaling leads to impaired skeletal muscle regeneration.
    Ge X; Vajjala A; McFarlane C; Wahli W; Sharma M; Kambadur R
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E90-102. PubMed ID: 22535746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.